dextroamphetamine has been researched along with Brain Disorders in 7 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Interestingly, firing rates of neurons in all groups decreased by fivefold or greater under urethane anesthesia, although the relative firing rates between hemispheres were unchanged." | 3.70 | Multiple single-unit recordings in the striatum of freely moving animals: effects of apomorphine and D-amphetamine in normal and unilateral 6-hydroxydopamine-lesioned rats. ( Gerhardt, GA; Kish, LJ; Palmer, MR, 1999) |
| "Bereavement after diagnosing AIDS or other HIV disease, psychological symptoms secondary to brain disease and the social consequences of having AIDS all interact to produce a devastating illness where the patient may be intensely grieving, demented and totally rejected by all of society." | 1.27 | Psychosocial aspects of AIDS. ( Goldmeier, D, 1987) |
| " The dose-response curves for D-amphetamine (1." | 1.27 | Acute exposure to triethyl lead enhances the behavioral effects of dopaminergic agonists: involvement of brain dopamine in organolead neurotoxicity. ( Dehaven, DL; Schulz, DW; Tilson, HA; Walsh, TJ, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kish, LJ | 1 |
| Palmer, MR | 1 |
| Gerhardt, GA | 1 |
| Schain, RJ | 1 |
| Goldmeier, D | 1 |
| Walsh, TJ | 1 |
| Schulz, DW | 1 |
| Tilson, HA | 1 |
| Dehaven, DL | 1 |
| Conners, CK | 1 |
| Wender, PH | 1 |
| Epstein, RS | 1 |
| Kopin, IJ | 1 |
| Gordon, EK | 1 |
| Baldwin, RL | 1 |
| Peters, JE | 1 |
1 review available for dextroamphetamine and Brain Disorders
| Article | Year |
|---|---|
Minimal brain Dysfunction.
Topics: Attention Deficit Disorder with Hyperactivity; Brain Diseases; Cerebral Palsy; Child; Child, Prescho | 1975 |
6 other studies available for dextroamphetamine and Brain Disorders
| Article | Year |
|---|---|
Multiple single-unit recordings in the striatum of freely moving animals: effects of apomorphine and D-amphetamine in normal and unilateral 6-hydroxydopamine-lesioned rats.
Topics: Anesthesia; Anesthetics, Intravenous; Animals; Apomorphine; Brain Diseases; Corpus Striatum; Dextroa | 1999 |
Psychosocial aspects of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Attitude to Health; Brain Diseases; Child; Dementia; Dextroamphe | 1987 |
Acute exposure to triethyl lead enhances the behavioral effects of dopaminergic agonists: involvement of brain dopamine in organolead neurotoxicity.
Topics: Animals; Apomorphine; Brain Diseases; Dextroamphetamine; Dopamine; Drug Interactions; Lead; Male; Mo | 1986 |
The effect of stimulant drugs on human figure drawings in children with minimal brain dysfunction.
Topics: Art; Attention; Brain Diseases; Child; Dextroamphetamine; Female; Humans; Male; Methylphenidate; Pla | 1971 |
Urinary monoamine metabolites in children with minimal brain dysfunction.
Topics: Adolescent; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Brain Damage, Chro | 1971 |
Hematologic complications from tranquilizers in children.
Topics: Adolescent; Age Factors; Agranulocytosis; Bone Marrow Examination; Brain Damage, Chronic; Brain Dise | 1968 |